Imprint | Sitemap | Search

Home

News

	Better prevention of transmission and lesion development of genital herpes predicted for AiCuris drug AIC316 16April2012
	Results of Letermovir (AIC246) Phase 2b in Prophylaxis of Human Cytomegalovirus in Recipients of Human Blood Precursor Cell Transplants meeting both primary Efficacy Endpoints to be presented at International Conferences 2April2012
	AiCuris Drug Letermovir (AIC246) meets primary efficacy endpoints in phase 2 for human cytomegalovirus (HCMV) prophylaxis in human blood precursor cell recipients 14Februrary2012
	AiCuris receives Orphan Drug Designation for Letermovir (AIC246) from FDA 05January2012
	No resistant herpes simplex virus (HSV) observed in phase II trial with AIC316, AiCuris' novel herpes drug 05September2011
	AiCuris’ HCMV Drug Letermovir (AIC246) receives Fast Track from FDA. New data at 51st ICAAC 28August2011
	AiCuris’ novel HSV compound AIC316 shows efficacy in phase II 18July2011
	AiCuris receives Orphan Drug Designation for its innovative phase II drug AIC246 for the prevention of HCMV disease 21April2011
	Dr. Marie-Paule Richard to join AiCuris as CMO 18Jan2011
	AiCuris completes Phase II genital herpes trial with AIC316 ahead of time 08Dec2010
	AiCuris gained Bio.NRW research promotion 29Nov2010
	AiCuris Presents Preclinical and Phase 1 Data of its anti-HSV drug AIC316 05Nov2010
	AiCuris Announces AIC246 to be Successful in Treatment of Multiorgan HCMV Disease 21 October 2010
	50th ICAAC, Boston AiCuris presents Phase I Safety and PK Data of the novel anti-HCMV terminase inhibitor AIC246 15 September 2010
	AiCuris presents mechanism of action investigations of its novel anti-HCMV drug AIC246 at the International Herpesvirus Workshop 19 July 2010
	AiCuris’ novel resistance breaking HIV compound AIC292 in Phase I 01 July 2010
	Novel HCMV compound of AiCuris in phase IIb trial with bone marrow transplant recipients 10 May 2010
	AiCuris raises 55 Mio EUR (75 Mio USD) 14 April 2010
	AiCuris successfully completed phase I for novel herpes compound 6 November 2009
	AiCuris' novel HCMV compound shows good tolerability and efficacy in phase II study 15 September 2009
	AiCuris to present phase II data for HCMV compound at ICAAC 26 August 2009

Download Archive

Press Release 16.04.2012
Press Release 02.04.2012
Press Release 14.02.2012
Press Release 05.01.2011
Press Release 05.09.2011
Press Release 29.08.2011
Press Release 18.07.2011
Press Release 21.04.2011
Press Release 18.01.2011
Press Release 08.12.2010
Press Release 29.11.2010
Press Release 05.11.2010
Press Release 21.10.2010